KEI is holding a December 2, 2016 meeting on the delinkage of R&D costs from drug prices.
The venue will be US Senate Hearing Room SD-106, Dirksen Office Building. The meeting will take place from 9:00am to 2:00pm.
A copy of the agenda is available here.
For more information about delinkage, see: http://delinkage.org.
To register for the event, please fill out this form: https://goo.gl/forms/AbP2npqLRLYneLjk1.
For more information about the event, contact claire.cassedy@keionline.org.
The topics discussed at the meeting will include:
- What is delinkage, and why is it important?
- Reform of pull mechanisms
- What are end product prizes, and how do they work?
- What is the open source dividend, how does it work, and why is it important?
- How interim results prizes work
- Making global norms for R&D funding (both push and pull)
- Strategies for progressive delinkage
- Next steps
Attached is the most recent agenda (as updates are released, we will update the agenda below). Speakers and respondents include:
- Aidan Hollis, Professor, Department of Economics, University of Calgary
- Dean Baker, co-Director of the Center for Economic and Policy Research
- Diane Singhroy, Scientific Advisor, Knowledge Ecology International
- Ellen ‘t Hoen, LLM. Medicines Law & Policy and Global Health Unit, University Medical Center Groningen, University of Groningen, The Netherlands.
- James Love, Knowledge Ecology International (KEI)
- James L. McGee, CEBS, Executive Director, Transit Employees’ Health & Welfare Fund
- Joe Larsen, Ph.D., Deputy Director (acting), Biomedical Advanced Research Development Authority (BARDA)
- John Wilbanks, Chief Commons Officer at Sage Bionetworks and a Senior Fellow at the Ewing Marion Kauffman Foundation and at FasterCures
- Judit Rius, Médecins sans frontières
- Katy Athersuch, Medical Innovation & Access Policy Adviser
- Manon Ress, Union for Affordable Cancer Treatment (UACT)
- Patrick Kilbride, Executive Director, International Intellectual Property, GIPC at U.S. Chamber of Commerce
- Rachel Cohen, DNDi
- Rishab Ghosh, Maastricht University
- Rob Weissman, President, Public Citizen
- Sakiko Fukuda-Parr. Professor of International Affairs, The New School in New York, member of the UN Secretary General High Level Panel on Access to Medicine.
- Tim Hubbard, Professor of Bioinformatics, King’s College London